Displaying all 7 publications

Abstract:
Sort:
  1. Tajunisah I, Patel DK
    J Emerg Med, 2013 Jan;44(1):164-5.
    PMID: 21820265 DOI: 10.1016/j.jemermed.2011.05.042
    Matched MeSH terms: Hypertension, Malignant/complications; Hypertension, Malignant/diagnosis*
  2. Tengku Kamalden, T.A., Choo, M.M., Fauzi, A.
    JUMMEC, 2006;9(2):32-34.
    MyJurnal
    Malignant hypertension affects less than 1% of people with high blood pressure, and is a hypertensive emergency. It is rare for patients to present initially with this form of elevated blood pressure, which is almost always associated with acute target organ damage, which can manifest in many forms including ocular, neurological, cardiac and renal. This treatable condition is associated with a high rate of morbidity and mortality therefore, early detection and immediate management is of paramount importance.
    Matched MeSH terms: Hypertension, Malignant
  3. Tajunisah I, Patel DK
    N. Engl. J. Med., 2009 Aug 27;361(9):899.
    PMID: 19710488 DOI: 10.1056/NEJMicm0802683
    Matched MeSH terms: Hypertension, Malignant/complications*
  4. Sulaiman W, Husin NM, Baba MS
    Oman Med J, 2011 Nov;26(6):e026.
    PMID: 28861180 DOI: 10.5001/omj.2011.119
    A 33-year old Malay woman with undiagnosed systemic lupus erythematosus (SLE) and other comorbids presented with acute glomerularnephritis, hypertensive emergency and later acute confusional state. Cranial MRI revealed features consistent with posterior reversible encephalopathy syndrome (PRES).
    Matched MeSH terms: Hypertension, Malignant
  5. Kanaheswari Y, Hamzaini AH, Wong SW, Zulfiqar A
    Acta Paediatr., 2008 Nov;97(11):1589-91.
    PMID: 18671691 DOI: 10.1111/j.1651-2227.2008.00971.x
    Phakomatosis pigmentovascularis (PPV) is a rare congenital syndrome characterized predominantly by cutaneous vascular malformations and pigmentary naevi. The most frequently reported form, Type II b, is associated with systemic involvement. Sturge-Weber Syndrome (SWS) with concomitant glaucoma, Klippel-Trenaunay Syndrome (KTS) and naevus of Ota have been frequently described, but there have only been two case reports with asymptomatic renal anomalies.
    Matched MeSH terms: Hypertension, Malignant/etiology*
  6. Sidek Nontak MA
    Med. J. Malaysia, 1981 Sep;36(3):181-5.
    PMID: 6120443
    A total of 12 severely hypertensive patients were treated with a once daily dose ofNadolol. There was a drop in diastolic pressure to a mean of 105 mm Hg standing within two weeks and this was well maintained up to 12 months of therapy, the lowest diastolic pressure being 94 mm Hg standing at six months of therapy. Nadolol produced no significant side effects and bradycardia was not a problem during treatment. Of the eleven patients who were resistant to previous therapy because of various reasons all except two responded excellently. One of the non responders has real resistance to therapy and the other is non compliant. Nadolol is found to be an effective once daily treatment for severe and resistant hypertension.
    Matched MeSH terms: Hypertension, Malignant/drug therapy*
  7. Zarina AL, Hamidah A, Zulkifli SZ, Zulfiqar MA, Jamal R
    Singapore Med J, 2007 Dec;48(12):e320-2.
    PMID: 18043827
    Pancreatic carcinoid tumours are rare, particularly within the paediatric population. The clinical presentation is largely dependent on the functionality of the tumour. Although the tumour is generally slow-growing, surgical resection is still the mainstay of curative treatment. Morbidity is, however, significantly contributed by secretion of excess hormones; in view of this, biotherapy is an important treatment strategy. Octreotide, a somatostatin analogue, has been shown to be successful in both symptomatic control and stability of tumour progression. We report a 12-year-old girl, who presented with hypertensive crisis, and showed good response to a combination of chemotherapy and octreotide.
    Matched MeSH terms: Hypertension, Malignant/diagnosis; Hypertension, Malignant/etiology
Related Terms
Filters
Contact Us

Please provide feedback to Administrator (tengcl@gmail.com)

External Links